ERBB2 and breast cancer: The primary treatment paradigm at presentation (depending on the disease stage) for HER2+ BC includes surgical resection, preceded or followed by a course of targeted therapies and combinatorial chemotherapies—though an effort is being made to reduce reliance on chemotherapy.